Indefinite Delivery Contract SPM2DX14D0972

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. The single-award IDC, valued up to $499,999,999, covers a comprehensive array of pharmaceutical items from common medications to specialized drugs and supplies. Through this vehicle, DMS Pharmaceutical Group delivers both routine and critical pharmaceuticals to fulfill the diverse medical requirements of Department of Defense healthcare facilities under the TRICARE West program. The contract has a period of performance through December 31, 2025, and includes firm fixed-price delivery orders placed by the DLA's Medical Supply Chain division, which distributes the products to various DoD sites. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD locations, solidifying the company's position as a key supplier in the federal pharmaceutical supply chain.